Showing results (1621-1630 of 2,004) with videos related to

Sort By:
Pageof 201
Phytotherapy Research : PTR|July 3, 2007
Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activitiesJung-Min Choi, Eun-Ok Lee, Hyo-Jung Lee, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 19, 2011
Saponins from the roots of Platycodon grandiflorum suppress ultraviolet A-induced matrix metalloproteinase-1 expression via MAPKs and NF-κB/AP-1-dependent signaling in HaCaT cellsYong Pil Hwang, Hyung Gyun Kim, Jae Ho Choi, et al.
European Neurology|January 6, 2017
The Association of Musculoskeletal Pain with Bone Mineral Density in Patients with Parkinson's DiseaseSeong-Min Choi, Byeong C Kim, Hyun-Jung Jung, et al.
Clinical and Experimental Reproductive Medicine|July 22, 2014
Vitamin D deficiency in women with polycystic ovary syndromeJin Ju Kim, Young Min Choi, Soo Jin Chae, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|August 20, 2015
Estrogen receptor beta gene polymorphisms and risk of recurrent pregnancy loss: a case-control studyJin Ju Kim, Young Min Choi, Sung Ki Lee, et al.
Plos One|December 9, 2014
Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790MKwang Sup So, Cheol Hyeon Kim, Jin Kyung Rho, et al.
International Journal of Clinical and Experimental Pathology|November 18, 2014
Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancerHo-Cheol Kim, Joon Seon Song, Jae Cheol Lee, et al.
Oncoimmunology|September 14, 2020
Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitorsSang Eun Won, Hyo Jung Park, Sangil Byun, et al.
Journal of Clinical Medicine|January 21, 2022
CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung CancerYunha Nam, Chang-Min Choi, Young Soo Park, et al.
Thoracic Cancer|December 9, 2021
Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancerSu Yeon Lee, Young Chul Kim, Kye Young Lee, et al.
Pageof 201